Karnataka home to hundreds of startups in med, pharma sectors: Minister MB Patil

BENGALURU: Karnataka is emerging as a key player in the dermatology and cosmetic medical treatment sectors, with significant investment opportunities coming up, particularly in the upcoming KWIN City project, said Industries and Infrastructure Development Minister MB Patil on Friday.

At the inauguration of the Bharat Summit of Laser Medicine and Surgery 2025, Patil highlighted the state’s advancements in medical device manufacturing and pharmaceutical startups and noted that Karnataka currently manufactures 350 critical medical instruments and is home to hundreds of startups in the medical and pharmaceutical sectors, which are actively driving healthcare innovation.

Patil emphasised that Karnataka is at the forefront of producing medical IT solutions, PCR machines, stents for heart treatments, insulin pens, and other key medical devices.

He added that the medical devices, digital health, and diagnostics sectors are undergoing rapid transformation, with state-based companies leading technological advancements in these areas.

During the four-day international conference, Patil stressed that affordable healthcare and speedy treatment are essential for building credibility in the industry. The conference, which will conclude on Sunday, March 23, brought together over 1,200 delegates from around the world for discussions.

Related Posts

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

New Delhi: In a major crackdown on the sale of expired and substandard products, the Central Range team of Delhi Police Crime Branch has arrested one person and seized nearly…

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

Washington:  On March 18, 2026, the U.S. Food and Drug Administration (FDA) issued a draft guidance titled General Considerations for the Use of New Approach Methodologies in Drug Development. The…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

IPC releases draft NFI-2026 to promote rational use of medicines

IPC releases draft NFI-2026 to promote rational use of medicines

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

US market to dent India pharma earnings even as domestic growth remains firm

US market to dent India pharma earnings even as domestic growth remains firm

Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg

Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg